Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BI 1181181 - Healthy
    Clinical Study Number 1344.2
    Study Indication Healthy
    Product BI 1181181
    Generic Name BI 1181181
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of BI 1181181 given orally q.d. for 10 days in young healthy male and elderly healthy male/female volunteers (randomized, double-blind, placebo controlled within dose groups, Phase I study)

    Study Document
    Trial statement 1344.2 english